CIK 0001177648
- Non-accelerated filer
- Smaller reporting company
ENANTA PHARMACEUTICALS INC
Sign in to watch- Ticker
- ENTA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Sep 30
- Entity type
- Operating
- EIN
- 043205099
- Phone
- +1 617-607-0800
- Business address
- 4 KINGSBURY AVENUE, WATERTOWN, MA, 02472
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Exercise or conversion Sr. VP & CSO acquired 13,693 shares (option exercise)
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Open-market sale Treasurer and CFO sold 6,000 shares at $45.58 ($273,463)
- 4 Shares withheld for taxes Sr. VP & General Counsel gave up 1,540 shares (to pay taxes)
- 4 Shares withheld for taxes Treasurer and CFO gave up 770 shares (to pay taxes)
- 4 Shares withheld for taxes Sr. VP & Chief Medical Officer gave up 1,540 shares (to pay taxes)
- 4 Shares withheld for taxes Sr. VP & CSO gave up 1,540 shares (to pay taxes)
- 4 Shares withheld for taxes President and CEO gave up 2,201 shares (to pay taxes)
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Exercise or conversion Sr. VP & General Counsel acquired 1,667 shares (option exercise)
- 4 Grant or award Sr. VP & General Counsel acquired 7,600 shares (grant or award)
Page 10 of 24 · 475 filings